HIT Consultant – …UPMC announces it will take majority stake in clinical decision support technology innovator medCPU, leads a $35M investment round to co-develop additional products with the goal of improving patient outcomes and will become a MedCPU customer.
Explore Our Insights
Read More
UPMC Enterprises Invests in Ouro Medicines to Advance New Autoimmune Therapies Through T-Cell Engagers and B-Cell Depletion
UPMC Enterprises Demonstrates its Community Commitment Through Support of Pittsburgh Economy
